Bayer is taking Baycol (cerivastatin) off the market

August 2001

Bayer is taking Baycol (cerivastatin) off the market...due to continued reports of severe muscle damage.

This has been a problem with higher doses of Baycol...or when used in combination with gemfibrozil (Lopid).

Patients will now have to switch to one of the other statins... Lescol, Lipitor, Mevacor, Pravachol, Zocor.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cholesterol Bayer is taking Baycol (cerivastatin) off the market
new thinking on which women should take hormone replacement therapy
Gastroenterology acid blockers for some patients with irritable bowel syndrome
Cardiology measuring C-reactive protein...to help identify patients who could benefit from statins
Infectious Diseases flu vaccine delay again this year
Infectious Diseases Valtrex (valacyclovir) for just 3 days for treating recurrent genital herpes
Parkinson's Disease new treatment algorithm to select drugs for Parkinson's disease
Dermatology topical phenytoin for wound healing
Dermatology Estrostep for acne in young women
Pediatrics iron deficiency might reduce cognitive ability in school-aged kids
Osteoporosis best way to switch women from estrogen replacement therapy to Evista (raloxifene)
Osteoporosis Men on gonadotropin-releasing hormone agonists (Lupron, etc) for prostate cancer
Anticoagulants new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep)
recognizing and treating postpartum depression
stronger warnings about prescribing OxyContin
Liver Disease which drugs require liver function tests